← Back to Clinical Trials
Recruiting NCT05505513

NCT05505513 Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05505513
Status Recruiting
Phase
Sponsor University of Utah
Condition Amputation
Study Type INTERVENTIONAL
Enrollment 3 participants
Start Date 2020-12-21
Primary Completion 2028-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
percutaneous Utah Slanted Electrode Arrays (pUSEAs)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 3 participants in total. It began in 2020-12-21 with a primary completion date of 2028-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators will investigate the device feasibility of human peripheral nerves and muscles recording and stimulation using percutaneous Utah Slanted Electrode Arrays (pUSEAs) implanted into residual peripheral arm nerves and EMG electrodes implanted in the residual muscles of patients with limb amputations in order to determine the ability of the HAPTIX (Hand Proprioception and Touch Interfaces) System to control an upper-extremity prosthesis, and to provide a sense of cutaneous touch and muscle proprioceptive feedback to the amputee.

Eligibility Criteria

Inclusion Criteria: * at least 18 years of age and less than 65 years of age * unilateral and bilateral traumatic or elective upper extremity amputations at the transradial level Exclusion Criteria: * incarceration * pregnancy * inability to consent * psychiatric comorbidity * medical conditions that significantly increase the risk of adverse effects of general anesthesia

Contact & Investigator

Central Contact

Douglas Hutchinson, M.D.

✉ Douglas.Hutchinson@hsc.utah.edu

📞 801-587-5400

Principal Investigator

Douglas Hutchinson, M.D.

PRINCIPAL INVESTIGATOR

University of Utah Orthopaedics

Frequently Asked Questions

Who can join the NCT05505513 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Amputation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05505513 currently recruiting?

Yes, NCT05505513 is actively recruiting participants. Contact the research team at Douglas.Hutchinson@hsc.utah.edu for enrollment information.

Where is the NCT05505513 trial being conducted?

This trial is being conducted at Salt Lake City, United States.

Who is sponsoring the NCT05505513 clinical trial?

NCT05505513 is sponsored by University of Utah. The principal investigator is Douglas Hutchinson, M.D. at University of Utah Orthopaedics. The trial plans to enroll 3 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology